Farmers & Merchants Investments Inc. Sells 10,342 Shares of CVS Health Co. (NYSE:CVS)

Farmers & Merchants Investments Inc. decreased its holdings in shares of CVS Health Co. (NYSE:CVS) by 3.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 266,371 shares of the pharmacy operator’s stock after selling 10,342 shares during the period. Farmers & Merchants Investments Inc.’s holdings in CVS Health were worth $11,957,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in CVS. MidAtlantic Capital Management Inc. acquired a new position in CVS Health in the third quarter valued at about $25,000. Ridgewood Investments LLC raised its position in shares of CVS Health by 255.7% in the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after acquiring an additional 450 shares during the period. Livelsberger Financial Advisory acquired a new position in CVS Health during the third quarter valued at approximately $31,000. Legacy Investment Solutions LLC acquired a new stake in CVS Health in the third quarter worth $31,000. Finally, Reston Wealth Management LLC acquired a new position in shares of CVS Health in the 3rd quarter valued at $32,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Down 0.5 %

CVS stock opened at $53.95 on Friday. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75. The firm has a market capitalization of $67.90 billion, a PE ratio of 13.69, a PEG ratio of 0.60 and a beta of 0.61. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The stock has a 50-day simple moving average of $50.79 and a two-hundred day simple moving average of $56.01.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.08 by $0.01. The firm had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business’s quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.21 earnings per share. On average, equities analysts predict that CVS Health Co. will post 5.14 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.93%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is 67.51%.

Analysts Set New Price Targets

CVS has been the topic of a number of research analyst reports. Royal Bank of Canada dropped their price target on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research report on Friday, November 15th. Mizuho reduced their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a report on Thursday, October 24th. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective on the stock in a research report on Tuesday, December 3rd. Barclays cut their target price on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research note on Thursday, November 7th. Finally, Piper Sandler lowered their target price on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a report on Monday, November 25th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat, CVS Health has a consensus rating of “Moderate Buy” and an average target price of $68.12.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.